US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 21, 2025

In Re Sana Biotechnology Inc Securities Litigation

Track this case

Case Number:

2:25-cv-00512

Court:

Washington Western

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Barbara J. Rothstein

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 17, 2025

    Sana Biotech Fights Investor Fraud Claims Over Trial Data

    Sana Biotechnology Inc. has asked a Seattle federal court to dismiss an investor suit over claims that it offered misleading statements regarding early clinical trials of a gene therapy, asserting that the company's disclosures were consistent with early-stage drug development risks.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login